Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis

Yoichi Nakagawa, Takahiro Oneyama, Haruhiko Terai, Akihiro Kanekawa, Hiroshi Iwabuchi, Satoshi Miyake, Isao Hasegawa, Masanori Nishikawa, Hideki Nakayama, Satoshi Nishimura, Jun Nosuke Hayashida, Kenichi Saito, Kojiro Onizawa, Masayuki Fukuda, Kanae Niimi, Takahiko Shibahara, Yoshinori Jinbu, Hitoshi Kawamata, Akihisa Tsurumoto, Tazuko SatohKatsunori Ishibashi, Akihiro Kaneko, Takahiro Miyasaka, Yoshiaki Kamikawa, Tomoari Kuriyama, Nobuko Maeda, Shoji Yamada, Tsutomu Sato, Fumiaki Ikeda, Intetsu Kobayashi

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of the study was to establish the response evaluation criteria of antifungal agents for oral candidiasis. Methods: A multicenter open-label trial was conducted. The patients with oral candidiasis were treated by an antifungal agent, itraconazole, and the response to the agent was evaluated according to the protocoL A multiple regression analysis was employed to examine the relative contribution of clinical signs and symptoms, including redness, white papules, atrophy of the papilla of the tongue, pain and soreness to the global evaluation of the responses judged by the attending physician. The global evaluation of the responses was rated as markedly improved, moderately improved or unchanged. Results: The multiple regression analysis showed that redness of the tongue and palate, white papules on the tongue, atrophy of the papillae of the tongue, and pain were associated with the global evaluation of the responses judged by the attending physician. Conclusion: Evaluation of these signs and symptoms could provide useful response information about antifungal therapy for oral candidiasis patients. Further studies will therefore be needed to verify the results of the present study.

Original languageEnglish
Pages (from-to)30-40
Number of pages11
JournalORAL THERAPEUTICS AND PHARMACOLOGY
Volume30
Issue number1
Publication statusPublished - Apr 1 2011

Fingerprint

Oral Candidiasis
Tongue
Antifungal Agents
Signs and Symptoms
Atrophy
Regression Analysis
Physicians
Therapeutics
Pain
Itraconazole
Palate

All Science Journal Classification (ASJC) codes

  • Dentistry(all)
  • Pharmacology
  • Pharmacology (medical)

Cite this

Nakagawa, Y., Oneyama, T., Terai, H., Kanekawa, A., Iwabuchi, H., Miyake, S., ... Kobayashi, I. (2011). Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis. ORAL THERAPEUTICS AND PHARMACOLOGY, 30(1), 30-40.

Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis. / Nakagawa, Yoichi; Oneyama, Takahiro; Terai, Haruhiko; Kanekawa, Akihiro; Iwabuchi, Hiroshi; Miyake, Satoshi; Hasegawa, Isao; Nishikawa, Masanori; Nakayama, Hideki; Nishimura, Satoshi; Hayashida, Jun Nosuke; Saito, Kenichi; Onizawa, Kojiro; Fukuda, Masayuki; Niimi, Kanae; Shibahara, Takahiko; Jinbu, Yoshinori; Kawamata, Hitoshi; Tsurumoto, Akihisa; Satoh, Tazuko; Ishibashi, Katsunori; Kaneko, Akihiro; Miyasaka, Takahiro; Kamikawa, Yoshiaki; Kuriyama, Tomoari; Maeda, Nobuko; Yamada, Shoji; Sato, Tsutomu; Ikeda, Fumiaki; Kobayashi, Intetsu.

In: ORAL THERAPEUTICS AND PHARMACOLOGY, Vol. 30, No. 1, 01.04.2011, p. 30-40.

Research output: Contribution to journalArticle

Nakagawa, Y, Oneyama, T, Terai, H, Kanekawa, A, Iwabuchi, H, Miyake, S, Hasegawa, I, Nishikawa, M, Nakayama, H, Nishimura, S, Hayashida, JN, Saito, K, Onizawa, K, Fukuda, M, Niimi, K, Shibahara, T, Jinbu, Y, Kawamata, H, Tsurumoto, A, Satoh, T, Ishibashi, K, Kaneko, A, Miyasaka, T, Kamikawa, Y, Kuriyama, T, Maeda, N, Yamada, S, Sato, T, Ikeda, F & Kobayashi, I 2011, 'Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis', ORAL THERAPEUTICS AND PHARMACOLOGY, vol. 30, no. 1, pp. 30-40.
Nakagawa, Yoichi ; Oneyama, Takahiro ; Terai, Haruhiko ; Kanekawa, Akihiro ; Iwabuchi, Hiroshi ; Miyake, Satoshi ; Hasegawa, Isao ; Nishikawa, Masanori ; Nakayama, Hideki ; Nishimura, Satoshi ; Hayashida, Jun Nosuke ; Saito, Kenichi ; Onizawa, Kojiro ; Fukuda, Masayuki ; Niimi, Kanae ; Shibahara, Takahiko ; Jinbu, Yoshinori ; Kawamata, Hitoshi ; Tsurumoto, Akihisa ; Satoh, Tazuko ; Ishibashi, Katsunori ; Kaneko, Akihiro ; Miyasaka, Takahiro ; Kamikawa, Yoshiaki ; Kuriyama, Tomoari ; Maeda, Nobuko ; Yamada, Shoji ; Sato, Tsutomu ; Ikeda, Fumiaki ; Kobayashi, Intetsu. / Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis. In: ORAL THERAPEUTICS AND PHARMACOLOGY. 2011 ; Vol. 30, No. 1. pp. 30-40.
@article{42ce826152ee4109af64d7a158080d17,
title = "Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis",
abstract = "Purpose: The purpose of the study was to establish the response evaluation criteria of antifungal agents for oral candidiasis. Methods: A multicenter open-label trial was conducted. The patients with oral candidiasis were treated by an antifungal agent, itraconazole, and the response to the agent was evaluated according to the protocoL A multiple regression analysis was employed to examine the relative contribution of clinical signs and symptoms, including redness, white papules, atrophy of the papilla of the tongue, pain and soreness to the global evaluation of the responses judged by the attending physician. The global evaluation of the responses was rated as markedly improved, moderately improved or unchanged. Results: The multiple regression analysis showed that redness of the tongue and palate, white papules on the tongue, atrophy of the papillae of the tongue, and pain were associated with the global evaluation of the responses judged by the attending physician. Conclusion: Evaluation of these signs and symptoms could provide useful response information about antifungal therapy for oral candidiasis patients. Further studies will therefore be needed to verify the results of the present study.",
author = "Yoichi Nakagawa and Takahiro Oneyama and Haruhiko Terai and Akihiro Kanekawa and Hiroshi Iwabuchi and Satoshi Miyake and Isao Hasegawa and Masanori Nishikawa and Hideki Nakayama and Satoshi Nishimura and Hayashida, {Jun Nosuke} and Kenichi Saito and Kojiro Onizawa and Masayuki Fukuda and Kanae Niimi and Takahiko Shibahara and Yoshinori Jinbu and Hitoshi Kawamata and Akihisa Tsurumoto and Tazuko Satoh and Katsunori Ishibashi and Akihiro Kaneko and Takahiro Miyasaka and Yoshiaki Kamikawa and Tomoari Kuriyama and Nobuko Maeda and Shoji Yamada and Tsutomu Sato and Fumiaki Ikeda and Intetsu Kobayashi",
year = "2011",
month = "4",
day = "1",
language = "English",
volume = "30",
pages = "30--40",
journal = "Oral Therapeutics and Pharmacology",
issn = "0288-1012",
publisher = "Japanese Society of Oral Therapeutics and Pharmacology",
number = "1",

}

TY - JOUR

T1 - Report of the committee for establishment of the response evaluation criteria of antifungal therapy for oral candidiasis

AU - Nakagawa, Yoichi

AU - Oneyama, Takahiro

AU - Terai, Haruhiko

AU - Kanekawa, Akihiro

AU - Iwabuchi, Hiroshi

AU - Miyake, Satoshi

AU - Hasegawa, Isao

AU - Nishikawa, Masanori

AU - Nakayama, Hideki

AU - Nishimura, Satoshi

AU - Hayashida, Jun Nosuke

AU - Saito, Kenichi

AU - Onizawa, Kojiro

AU - Fukuda, Masayuki

AU - Niimi, Kanae

AU - Shibahara, Takahiko

AU - Jinbu, Yoshinori

AU - Kawamata, Hitoshi

AU - Tsurumoto, Akihisa

AU - Satoh, Tazuko

AU - Ishibashi, Katsunori

AU - Kaneko, Akihiro

AU - Miyasaka, Takahiro

AU - Kamikawa, Yoshiaki

AU - Kuriyama, Tomoari

AU - Maeda, Nobuko

AU - Yamada, Shoji

AU - Sato, Tsutomu

AU - Ikeda, Fumiaki

AU - Kobayashi, Intetsu

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Purpose: The purpose of the study was to establish the response evaluation criteria of antifungal agents for oral candidiasis. Methods: A multicenter open-label trial was conducted. The patients with oral candidiasis were treated by an antifungal agent, itraconazole, and the response to the agent was evaluated according to the protocoL A multiple regression analysis was employed to examine the relative contribution of clinical signs and symptoms, including redness, white papules, atrophy of the papilla of the tongue, pain and soreness to the global evaluation of the responses judged by the attending physician. The global evaluation of the responses was rated as markedly improved, moderately improved or unchanged. Results: The multiple regression analysis showed that redness of the tongue and palate, white papules on the tongue, atrophy of the papillae of the tongue, and pain were associated with the global evaluation of the responses judged by the attending physician. Conclusion: Evaluation of these signs and symptoms could provide useful response information about antifungal therapy for oral candidiasis patients. Further studies will therefore be needed to verify the results of the present study.

AB - Purpose: The purpose of the study was to establish the response evaluation criteria of antifungal agents for oral candidiasis. Methods: A multicenter open-label trial was conducted. The patients with oral candidiasis were treated by an antifungal agent, itraconazole, and the response to the agent was evaluated according to the protocoL A multiple regression analysis was employed to examine the relative contribution of clinical signs and symptoms, including redness, white papules, atrophy of the papilla of the tongue, pain and soreness to the global evaluation of the responses judged by the attending physician. The global evaluation of the responses was rated as markedly improved, moderately improved or unchanged. Results: The multiple regression analysis showed that redness of the tongue and palate, white papules on the tongue, atrophy of the papillae of the tongue, and pain were associated with the global evaluation of the responses judged by the attending physician. Conclusion: Evaluation of these signs and symptoms could provide useful response information about antifungal therapy for oral candidiasis patients. Further studies will therefore be needed to verify the results of the present study.

UR - http://www.scopus.com/inward/record.url?scp=79956342906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956342906&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79956342906

VL - 30

SP - 30

EP - 40

JO - Oral Therapeutics and Pharmacology

JF - Oral Therapeutics and Pharmacology

SN - 0288-1012

IS - 1

ER -